BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status
Genevieve Evin, Christopher Hince
DRUGS & AGING | ADIS INT LTD | Published : 2013
The authors acknowledge funding support from the Judith Jane Mason and Harold Stannett Williams Memorial Foundation. The authors have no conflicts of interest that are directly relevant to the content of this review.